bioRxivMolecular BiologyPreprint
A transient modified mRNA encoding Myc and Cyclin T1 induces cardiac regeneration and improves cardiac function after myocardial injury
Aleksandra Boikova, Gregory A. Quaife-RyaniD, Christopher A. P. BathoiD, Elsa LawrenceiD, Harley RobinsoniD, Camilla AscanelliiD, Karin JennbackeniD, Qing‐Dong WangiD, Kenny M. HanssoniD, Adam Seaton, Victoria Rodriguez Noci, Megan J. BywateriD, Jasmin StraubeiD, Kamil A. SokolowskiiD, Brian WC Tse, Thomas KriegiD, Ana VujićiD, Enzo R. PorrelloiD, Sanjay SinhaiD, James E. HudsoniD, Catherine H. WilsoniD
Abstract
Cardiac injury, such as myocardial infarction (MI), results in permanent loss of cardiomyocytes and in many cases heart failure. Transgenic expression of the pro-proliferative transcription factor Myc and Cyclin T1 can drive substantial adult cardiomyocyte proliferation to replace lost cardiomyocytes. Herein, we show that Myc and Cyclin T1 induced cardiomyocyte proliferation leads to myocardial repair and functional (long-term) recovery post-MI in mice. To provide a more translational approach, we developed modified mRNA (modRNA) encoding Myc-Ccnt1 as a transient and non-integrating strategy for regeneration. One dose of Myc-Ccnt1 modRNA is sufficient to transiently drives cardiomyocyte proliferation in human pluripotent stem cell-derived cardiomyocytes and a mouse MI model, where it leads to better heart function. Using single nuclei sequencing and proteomics, we show this was functionally mediated by transcriptional activation of cell-cycle regulating genes, which ultimately results in mitosis and cytokinesis of cardiomyocytes. Collectively, these findings indicate that Myc-Ccnt1 modRNA has the potential to be an effective regenerative therapeutic.
- Citations
- 8
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mycn Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction
Aina Hirofuji, Hiroki Tanaka, … Kyohei Oyama·Journal of the American Heart AssociationPeer-reviewed·Apr 9, 2026
- Robust Myocardial Regeneration After Selective Cardiomyocyte Loss Is Driven by Cardiac Stem Cell Activation Through the miR-221-p57 Axis
Eleonora Cianflone, Fabiola Marino, … Daniele Torella·bioRxiv·Jul 13, 2026
- Activation of developmental transcription factors using RNA technology promotes heart repair
Riley J. Leonard, Mason Sweat, … Brad A. Amendt·bioRxiv·Jan 18, 2026
- A microRNA program controls the transition of cardiomyocyte hyperplasia to hypertrophy and stimulates mammalian cardiac regeneration
Andrea Raso, Ellen Dirkx, … León J. De Windt·Nature CommunicationsPeer-reviewed·Aug 10, 2021
- In situ maturated early-stage human induced pluripotent stem cell-derived cardiomyocytes improve cardiac function by enhancing segmentary contraction in infarcted rats
D. Biagi, E. T. Fantozzi, … R. Dariolli·bioRxiv·Mar 9, 2021
- Recombinant Protein IGF1-24 Stimulates Rat Cardiomyocytes Proliferation and Repairs Myocardial Injury
Xing Wang, Manxue Fu, … Liling Tang·bioRxiv·Mar 4, 2020